A murine model for escherichia coli urinary tract infection

Methods in Molecular Biology

Volumn 1333, Issue , 2016, Pages 159-175

  Hannan, Thomas J ^a   Hunstad, David A ^a  

^a NONE

Author keywords

Bacterial persistence; Cystitis; Escherichia coli; Intracellular bacterial community; Urinary tract infection

Indexed keywords

CYTOKINE;

BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM PILUS; BLADDER EPITHELIUM; CONFOCAL MICROSCOPY; CYTOPLASM; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXPERIMENTAL CYSTITIS; FLOW CYTOMETRY; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MICROBIAL COMMUNITY; MOUSE; MURINE MODEL; MUTANT MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PYELONEPHRITIS; RECURRENT INFECTION; TISSUE HOMOGENATE; URETHRAL CATHETERIZATION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; BLADDER; CYSTITIS; DISEASE MODEL; FEMALE; GENETICS; HUMAN; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; URINARY CATHETER; URINARY TRACT INFECTIONS; UROTHELIUM;

ANIMALS; CYSTITIS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; URINARY BLADDER; URINARY CATHETERS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM;

EID: 84945208957     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2854-5_14     Document Type: Chapter

References (67)

1. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M (2005) Urologic Diseases in America Project: analytical methods and principal findings. J Urol 173 (3):933-937
2. Andriole VT, Patterson TF (1991) Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 75(2):359-373
3. Ronald A, Ludwig E (2001) Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 17(4):287-292
4. Nicolle LE (2005) Catheter-related urinary tract infection. Drugs Aging 22(8):627-639
5. Flanigan TP, Hogan JW, Smith D, Schoenbaum E, Vlahov D, Schuman P, Mayer K (1999) Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clin Infect Dis 29(3):608-612
6. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE (2000) Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182(4):1177-1182
7. Eschenbach DA, Patton DL, Hooton TM, Meier AS, Stapleton A, Aura J, Agnew K (2001) Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium. J Infect Dis 183(6):913-918
8. Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53-70
9. Brauner A, Jacobson SH, Kuhn I (1992) Urinary Escherichia coli causing recurrent infections: a prospective follow-up of biochemical phenotypes. Clin Nephrol 38(6):318-323
10. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP (2001) Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 114(Pt 22):4095-4103
11. Dodson KW, Jacob-Dubuisson F, Striker RT, Hultgren SJ (1993) Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes. Proc Natl Acad Sci U S A 90(8):3670-3674
12. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN (2007) TLR4-initiated and cAMPmediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1(4):287-298
13. Wright KJ, Seed PC, Hultgren SJ (2007) Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 9(9):2230-2241
14. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA (2008) Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol 10 (12):2553-2567
15. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ (2001) Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharidedependent mechanism. J Immunol 166 (2):1148-1155
16. Berry RE, Klumpp DJ, Schaeffer AJ (2009) Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun 77 (7):2762-2772
17. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19(12):2803-2812
18. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003) Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301(5629):105-107
19. Mulvey MA, Schilling JD, Hultgren SJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69(7):4572-4579
20. Eto DS, Jones TA, Sundsbak JL, Mulvey MA (2007) Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3(7), e100
21. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN (2004) Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 279(18):18944-18951
22. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN (2007) Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13 (5):625-630
23. Eto DS, Sundsbak JL, Mulvey MA (2006) Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 8(4):704-717
24. Martinez JJ, Hultgren SJ (2002) Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli. Cell Microbiol 4(1):19-28
25. Doye A, Mettouchi A, Bossis G, Clement R, Buisson-Touati C, Flatau G, Gagnoux L, Piechaczyk M, Boquet P, Lemichez E (2002) CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 111 (4):553-564
26. Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H (2002) Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol Med Microbiol 33 (1):23-26
27. Terada N, Ohno N, Saitoh S, Saitoh Y, Fujii Y, Kondo T, Katoh R, Chan C, Abraham SN, Ohno S (2009) Involvement of dynamin-2 in formation of discoid vesicles in urinary bladder umbrella cells. Cell Tissue Res 337(1):91-102
28. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon JM, Fernandez B, Hertig A, Rondeau E, Arlet G, Hornef MW, Vandewalle A (2008) TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol 19(12):2364-2374
29. Pichon C, Hechard C, du Merle L, Chaudray C, Bonne I, Guadagnini S, Vandewalle A, Le Bouguenec C (2009) Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells. Cell Microbiol 11 (4):616-628
30. Szabados F, Kleine B, Anders A, Kaase M, Sakinc T, Schmitz I, Gatermann S (2008) Staphylococcus saprophyticus ATCC 15305 is internalized into human urinary bladder carcinoma cell line 5637. FEMS Microbiol Lett 285(2):163-169
31. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ (2008) Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 76(7):3337-3345
32. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ (2004) Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101 (5):1333-1338
33. Horvath DJ Jr, Li B, Casper T, Partida-Sanchez S, Hunstad DA, Hultgren SJ, Justice SS (2011) Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 13(5):426-437
34. Justice SS, Hunstad DA, Seed PC, Hultgren SJ (2006) Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 103 (52):19884-19889
35. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282(5393):1494-1497
36. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, Sun TT, Schaeffer AJ, Klumpp DJ (2009) Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5(5), e1000415
37. Thumbikat P, Berry RE, Schaeffer AJ, Klumpp DJ (2009) Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect 11(1):57-65
38. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ (2006) Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 74(9):5106-5113
39. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Vignoli R (2013) Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog Dis 68(3):78-81
40. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4(12), e329
41. Hunstad DA, Justice SS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64:203-221
42. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C (1984) Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/ HeN mice. Infect Immun 46(3):839-844
43. Hedges S, Anderson P, Lidin-Janson G, de Man P, Svanborg C (1991) Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect Immun 59(1):421-427
44. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C (2004) Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72(6):3179-3186
45. Artifoni L, Negrisolo S, Montini G, Zucchetta P, Molinari PP, Cassar W, Destro R, Anglani F, Rigamonti W, Zacchello G, Murer L (2007) Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol 177(3):1102-1106
46. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, Karpman D, Andersson B, Svanborg C (2007) Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 195(8):1227-1234
47. Lundstedt AC, McCarthy S, Gustafsson MC, Godaly G, Jodal U, Karpman D, Leijonhufvud I, Linden C, Martinell J, Ragnarsdottir B, Samuelsson M, Truedsson L, Andersson B, Svanborg C (2007) A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2(9), e825
48. Ragnarsdottir B, Jonsson K, Urbano A, Gronberg-Hernandez J, Lutay N, Tammi M, Gustafsson M, Lundstedt AC, Leijonhufvud I, Karpman D, Wullt B, Truedsson L, Jodal U, Andersson B, Svanborg C (2010) Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5(5), e10734
49. Svensson M, Irjala H, Svanborg C, Godaly G (2008) Effects of epithelial and neutrophil CXCR2 on innate immunity and resistance to kidney infection. Kidney Int 74(1):81-90
50. Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ (2007) Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 75(11):5353-5360
51. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14(4):399-406
52. Hilbert DW, Pascal KE, Libby EK, Mordechai E, Adelson ME, Trama JP (2008) Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide-and Toll-like receptor 4-independent pathway. Microbes Infect 10(2):114-121
53. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ (2005) Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73 (7):3999-4006
54. Klumpp DJ, Weiser AC, Sengupta S, Forrestal SG, Batler RA, Schaeffer AJ (2001) Uropathogenic Escherichia coli potentiates type 1 pilusinduced apoptosis by suppressing NF-κB. Infect Immun 69(11):6689-6695
55. Davis JM, Carvalho HM, Rasmussen SB, O’Brien AD (2006) Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun 74(8):4401-4408
56. Davis JM, Rasmussen SB, O’Brien AD (2005) Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 73(9):5301-5310
57. Lau ME, Loughman JA, Hunstad DA (2012) YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration. Infect Immun 80(12):4123-4132
58. Loughman JA, Hunstad DA (2011) Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect 13(6):555-565
59. Loughman JA, Hunstad DA (2012) Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis 205 (12):1830-1839
60. Mysorekar IU, Hultgren SJ (2006) Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 103 (38):14170-14175
61. Schilling JD, Lorenz RG, Hultgren SJ (2002) Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70(12):7042-7049
62. Hannan TJ, Mysorekar IU, Hung CS, Isaacson-Schmid ML, Hultgren SJ (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6(8), e1001042
63. Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Schembri MA, Hultgren SJ (2012) Hostpathogencheckpointsandpopulationbottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 36(3):616-648
64. Hopkins WJ, Hall JA, Conway BP, Uehling DT (1995) Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model. J Infect Dis 171 (2):462-465
65. Murawski IJ, Watt CL, Gupta IR (2011) Vesicoureteric reflux: using mouse models to understand a common congenital urinary tract defect. Pediatr Nephrol 26 (9):1513-1522
66. Wang C, Mendonsa GR, Symington JW, Zhang Q, Cadwell K, Virgin HW, Mysorekar IU (2012) Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo. Proc Natl Acad Sci U S A 109(27):11008-11013
67. Valdivia RH, Hromockyj AE, Monack D, Ramakrishnan L, Falkow S (1996) Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions. Gene 173(1):47-52